Patents by Inventor Jouko Uusitalo

Jouko Uusitalo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained-release silica composite depot non-steroidal anti-inflammatory drug delivery
    Patent number: 10548843
    Abstract: There is provided a depot suitable for sustained-release drug delivery, said depot including a composite body comprising particles having at least one encapsulated active pharmaceutical ingredient The depot includes 50 to 95 wt % of the composite body particles, said composite body particles having 0.1 to 80 wt % of active pharmaceutical ingredient, and the active pharmaceutical ingredient is a non-steroidal anti-inflammatory drug. In addition, the composite body is formed of a silica hydrogel comprising the silica particles.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: February 4, 2020
    Assignee: Solani Therapeutics Ltd
    Inventors: Elina Niskanen, Jaana Karjalainen, Jouko Uusitalo
  • Cellulose cartridge
    Publication number: 20190143045
    Abstract: According to an example aspect of the present invention, there is provided a cartridge for the delivery of medicine to mammals in veterinary applications comprising a non-woven cellulose tube having a closed end and an open end, wherein at least one cross-sectional area of the closed end is axially symmetric in relation to the longitudinal axis of the tube and the open end is plugged e.g. by folding or crushing the open end, or by inserting a cellulose cap, a disintegrating cap or a soluble cap.
    Type: Application
    Filed: May 5, 2017
    Publication date: May 16, 2019
    Inventors: Elina Niskanen, Jaana Karjalainen, Jouko Uusitalo
  • SUSTAINED-RELEASE NON-STEROIDAL ANTI-INFLAMMATORY DRUG DELIVERY
    Publication number: 20180311165
    Abstract: According to an example aspect of the present invention, there is provided a depot suitable for sustained-release drug delivery, said depot comprising a composite body comprising particles having at least one encapsulated active pharmaceutical ingredient The depot comprises 50 to 95 wt % of the composite body particles, said composite body particles comprising 0.1 to 80 wt % of active pharmaceutical ingredient, and the active pharmaceutical ingredient is a non-steroidal anti-inflammatory drug.
    Type: Application
    Filed: October 31, 2016
    Publication date: November 1, 2018
    Inventors: Elina Niskanen, Jaana Karjalainen, Jouko Uusitalo